Daniele Generali

928 total citations
26 papers, 475 citations indexed

About

Daniele Generali is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Daniele Generali has authored 26 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Daniele Generali's work include Cancer-related Molecular Pathways (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Breast Cancer Treatment Studies (4 papers). Daniele Generali is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Breast Cancer Treatment Studies (4 papers). Daniele Generali collaborates with scholars based in Italy, United States and United Kingdom. Daniele Generali's co-authors include Navid Sobhani, Yong Li, Raheleh Roudi, Aram Davtyan, Pedro O. Flores-Villanueva, Chunmei Fan, Alberto D’Angelo, Tobias Otto, Anne Fassl and Andrea Rocca and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Daniele Generali

24 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniele Generali Italy 10 232 156 121 114 84 26 475
Junya Ohtake Japan 10 296 1.3× 192 1.2× 276 2.3× 54 0.5× 68 0.8× 18 524
Georgia Gomatou Greece 11 260 1.1× 161 1.0× 47 0.4× 270 2.4× 75 0.9× 33 522
Yuki Katayama Japan 12 369 1.6× 226 1.4× 81 0.7× 218 1.9× 120 1.4× 30 619
Teresa Gelardi Italy 12 296 1.3× 234 1.5× 97 0.8× 193 1.7× 70 0.8× 13 569
Weiwei Shi China 11 128 0.6× 198 1.3× 85 0.7× 81 0.7× 67 0.8× 21 450
Ashwat Nagarajan United States 3 335 1.4× 178 1.1× 313 2.6× 68 0.6× 59 0.7× 4 620
Noam Auslander United States 5 422 1.8× 316 2.0× 233 1.9× 180 1.6× 130 1.5× 10 708
Serena Zanotta Italy 13 203 0.9× 86 0.6× 197 1.6× 97 0.9× 35 0.4× 22 393
Xinxin Zhu China 13 387 1.7× 157 1.0× 242 2.0× 144 1.3× 111 1.3× 19 650
Shaocong Wu China 10 199 0.9× 255 1.6× 96 0.8× 80 0.7× 130 1.5× 14 454

Countries citing papers authored by Daniele Generali

Since Specialization
Citations

This map shows the geographic impact of Daniele Generali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Generali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Generali more than expected).

Fields of papers citing papers by Daniele Generali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniele Generali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Generali. The network helps show where Daniele Generali may publish in the future.

Co-authorship network of co-authors of Daniele Generali

This figure shows the co-authorship network connecting the top 25 collaborators of Daniele Generali. A scholar is included among the top collaborators of Daniele Generali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniele Generali. Daniele Generali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rocca, Andrea, Lucio Crinò, Luca Braga, et al.. (2025). Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies. British Journal of Cancer. 133(10). 1405–1427.
2.
Catalano, Martina, Alberto D’Angelo, Francesco De Logu, et al.. (2025). Navigating Cancer Complexity: Integrative Multi-Omics Methodologies for Clinical Insights. Clinical Medicine Insights Oncology. 19. 1393505542–1393505542. 1 indexed citations
3.
Donofrio, Carmine Antonio, Antonio Fioravanti, Maria Rosa Cappelletti, et al.. (2025). Determination of longitudinal Circulating levels of miR-21-5p, miR-23b-3p and miR-34a-5p in plasma of patients with glioblastoma using droplet digital PCR. Neurosurgical Review. 48(1). 592–592.
4.
Sobhani, Navid, et al.. (2024). Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion. Cancers. 16(17). 3089–3089. 10 indexed citations
5.
Recinella, Lucia, Raúl M. Luque, Daniele Generali, et al.. (2024). The Protective Effects of an Aged Black Garlic Water Extract on the Prostate. Nutrients. 16(17). 3025–3025. 5 indexed citations
6.
Sobhani, Navid, Dafei Chai, Daniele Generali, et al.. (2024). Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancer. PubMed. 2(1). 13 indexed citations
7.
Schettini, Francesco, Estela Pineda, Andrea Rocca, et al.. (2024). Identifying the best treatment choice for relapsing/refractory glioblastoma: a systematic review with multiple Bayesian network meta-analyses. The Oncologist. 30(7). 2 indexed citations
8.
Paolis, Elisa De, Ida Paris, Bruno Tilocca, et al.. (2023). Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine. Frontiers in Oncology. 12. 1053035–1053035. 4 indexed citations
9.
Ganzinelli, Monica, Federica Guffanti, Navid Sobhani, et al.. (2023). Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair. Cancers. 15(17). 4309–4309. 2 indexed citations
10.
Bortul, Marina, Fabiola Giudici, Daniele Generali, et al.. (2023). A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection. International Journal of Molecular Sciences. 24(10). 8520–8520. 5 indexed citations
11.
Grassi, Gabriele, et al.. (2023). Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications. International Journal of Molecular Sciences. 24(11). 9688–9688. 12 indexed citations
12.
Miglietta, Federica, Alessandra Fabi, Daniele Generali, et al.. (2023). Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review. Cancer Treatment Reviews. 114. 102511–102511. 6 indexed citations
13.
Sobhani, Navid, Andrea Rocca, Alberto D’Angelo, et al.. (2023). Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report. Biomedicines. 11(2). 311–311. 9 indexed citations
14.
Ottaviani, Giulia, Giada Targato, Katia Rupel, et al.. (2023). Oral Problems in Oncology Patients Undergoing Chemotherapy for Solid Tumors: A Prospective Observational Study. Cancers. 16(1). 176–176. 2 indexed citations
15.
Salton, Francesco, Paola Confalonieri, Giuseppina Campisciano, et al.. (2022). Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS. Journal of Clinical Medicine. 11(11). 2951–2951. 51 indexed citations
16.
Rocca, Andrea, Luca Braga, Maria Concetta Volpe, Serena Maiocchi, & Daniele Generali. (2022). The Predictive and Prognostic Role of RAS–RAF–MEK–ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets. Cancers. 14(21). 5306–5306. 31 indexed citations
17.
Sobhani, Navid, et al.. (2021). CTLA-4 in Regulatory T Cells for Cancer Immunotherapy. Cancers. 13(6). 1440–1440. 181 indexed citations
18.
Sobhani, Navid, et al.. (2021). Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer. Cells. 10(2). 293–293. 39 indexed citations
19.
Sobhani, Navid, Alberto D’Angelo, Xu Wang, et al.. (2020). Mutant p53 as an Antigen in Cancer Immunotherapy. International Journal of Molecular Sciences. 21(11). 4087–4087. 14 indexed citations
20.
Sirico, Marianna, Ottavia Bernocchi, Navid Sobhani, et al.. (2020). Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer. Cancers. 12(11). 3314–3314. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junya Ohtake Breakdown of academic impact, for papers by Georgia Gomatou Breakdown of academic impact, for papers by Yuki Katayama Breakdown of academic impact, for papers by Teresa Gelardi Breakdown of academic impact, for papers by Weiwei Shi Breakdown of academic impact, for papers by Ashwat Nagarajan Breakdown of academic impact, for papers by Noam Auslander Breakdown of academic impact, for papers by Serena Zanotta Breakdown of academic impact, for papers by Xinxin Zhu Breakdown of academic impact, for papers by Shaocong Wu
Rankless by CCL
2026